Get the latest public health information from CDC: https://www.coronavirus.gov
Get the latest research information from NIH: https://www.covid19.nih.gov/
NIH staff guidance on coronavirus (NIH Only): https://employees.nih.gov/pages/coronavirus/
- Home
- About NICHD
- Organization
- Division of Extramural Research (DER)
- Extramural Scientific Branches
- Obstetric and Pediatric Pharmacology and Therapeutics Branch (OPPTB)
- Branch-Specific Funding Opportunities and Notices
OPPTB Funding Opportunities and Notices
NICHD publishes and participates in various Funding Opportunity Announcements (FOAs) and NIH Guide Notices (NOTs) to support research and training activities. The following table includes branch-specific FOAs, sorted by date from most recent to older. Select a table heading to change how the information is sorted.
A listing of NICHD-specific NOTs is available on the Active FOAs and NOTs page.
Please note: the following are sorted alphabetically by announcement number. Select a table heading to change how the information is sorted.
| Announcement Number | Submissions Date(s) | Expiration Date | Activity Code(s) | Title |
|---|---|---|---|---|
| RFA-HD-21-025 | November 30, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
December 1, 2020 | P30 | Maternal and Pediatrics Precision in Therapeutics Hub (MPRINT) (P30 Clinical Trial Not Allowed) |
| RFA-HD-21-026 | November 30, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
December 1, 2020 | P50 | Maternal and Pediatrics Precision in Therapeutics Hub (MPRINT) (P50 Clinical Trial Optional) |
| RFA-HD-21-014 | May 27, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
July 1, 2020 | T32 | Postdoctoral Training in Pediatric Clinical Pharmacology (T32 Clinical Trial Not Allowed) |
| PAR-17-191 | Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
May 8, 2020 | R03 | Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R03) |
| PAR-17-192 | Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
May 8, 2020 | R21 | Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R21) |
| PAR-17-193 | Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
May 8, 2020 | R01 | Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R01) |
| PAR-17-199 | Standard dates apply, by 5:00 PM local time of applicant organization. *** Note new SBIR/STTR Standard Due Dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
January 6, 2020 | R43 | Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R43) |
| PAR-17-200 | Standard dates apply, by 5:00 PM local time of applicant organization. *** Note new SBIR/STTR Standard Due Dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
January 6, 2020 | R41 | Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R41) |
| PAR-17-188 | August 7, 2017; November 7, 2017; April 4, 2018; August 7, 2018; November 7, 2018; April 4, 2019; August 7, 2019; November 7, 2019; April 3, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. | July 4, 2020 | R03 | Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R03) |
| PAR-17-187 | August 7, 2017; November 7, 2017; April 4, 2018; August 7, 2018; November 7, 2018; April 4, 2019; August 7, 2019; November 7, 2019; April 3, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. | July 4, 2020 | R21 | Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21) |
| PAR-17-189 | August 7, 2017; November 7, 2017; April 4, 2018; August 7, 2018; November 7, 2018; April 4, 2019; August 7, 2019; November 7, 2019; April 3, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. | July 4, 2020 | R01 | Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R01) |
| PAR-17-169 | Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. | May 8, 2020 | R21 | Biomarkers: Bridging Pediatric and Adult Therapeutics (R21) |
BACK TO TOP